- Home
- AXIL vs TIL Comparison
AXIL vs TIL Comparison
Compare AXIL & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXIL | TIL |
|---|---|---|
| Founded | 2015 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.7M | 54.8M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AXIL | TIL |
|---|---|---|
| Price | $6.85 | $8.07 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $125.00 |
| AVG Volume (30 Days) | 24.8K | ★ 26.7K |
| Earning Date | 04-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.06 |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $26,257,522.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $46.67 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.28 | $5.67 |
| 52 Week High | $10.25 | $42.75 |
Technical Indicators
Market Signals| Indicator | AXIL | TIL |
|---|---|---|
| Relative Strength Index (RSI) | 48.01 | 46.40 |
| Support Level | $6.63 | $7.95 |
| Resistance Level | $7.33 | $8.29 |
| Average True Range (ATR) | 0.33 | 0.19 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 54.69 | 37.26 |
Price Performance
Historical ComparisonAbout AXIL AXIL Brands Inc.
AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.